STOCK TITAN

If You Invested in Starling Oncology, Inc. (STLN)

Healthcare · Medical Care Facilities · NASDAQ
Looking for the current price? See the STLN quote & overview
$1,000 invested 1 Year Ago
$1,759
+75.9% price return 76.2% CAGR
+75.9% with dividends reinvested
Bought on Nov 6, 2025 at $3.81 split-adjusted
$1,000 invested 5 Years Ago
$671
-32.9% price return -7.7% CAGR
-32.9% with dividends reinvested
Bought on Nov 8, 2021 at $9.98 split-adjusted
$1,000 invested 10 Years Ago
N/A
Our prices start Jun 4, 2020

What $1,000 or $10,000 in STLN Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jun 4, 2020
$1,000 $1,759 +76% $671 -33% — $691 -31%
$10,000 $17,585 +76% $6,713 -33% — $6,907 -31%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-05. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for STLN

$1,000 Investment Over Time

STLN vs S&P 500

Year-by-Year Returns

STLN annual performance
Year Start Price End Price Annual Return Cumulative
2020Jun 4, 2020 to Dec 31, 2020 $9.70 $10.80 +11.3% +11.3%
2021 $10.80 $9.75 -9.7% +0.5%
2022 $9.75 $1.65 -83.1% -83.0%
2023 $1.65 $2.04 +23.6% -79.0%
2024 $2.04 $0.3090 -84.9% -96.8%
2025 $0.3090 $3.56 +1,052.1% -63.3%
2026Dec 31, 2025 to Nov 5, 2026 $3.56 $6.70 +88.2% -30.9%

About Starling Oncology, Inc.

Healthcare · NASDAQ

Market Cap
$0.7B
Current Price
$6.70
EPS (FY2025)
-$0.54
Revenue (FY2025)
$0.5B
Net Margin (FY2025)
-12.1%
View full STLN overview

Frequently Asked Questions

Starling Oncology, Inc. investment returns

How much would $1,000 invested in Starling Oncology, Inc. be worth today?

If you invested $1,000 in Starling Oncology, Inc. (STLN) 5 years ago on 2021-11-08, your investment would be worth $671 as of 2026-11-05, a -32.9% price return without dividends, growing at a compounded rate of -7.7% per year (CAGR).

Has Starling Oncology, Inc. outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare STLN performance over available time periods.

What is Starling Oncology, Inc.'s average annual return?

The compound annual growth rate (CAGR) of STLN’s share price over the past 5 years is -7.7%, without dividends. Individual years vary a great deal, and STLN’s best recent full year was 2025 (+1,052.1%) while the worst was 2024 (-84.9%).

For informational and educational purposes only, not investment advice.